PI3K/Akt signaling transduction pathway, erythropoiesis and glycolysis in hypoxia (Review)
Copyright: © Xie et al. This is an open access article distributed under the terms of Creative Commons Attribution License. The PI3K/Akt pathway is an intracellular signaling pathway of great importance in the cell cycle process. It is associated with cellular quiescence, proliferation, cancer and longevity. PI3K activation phosphorylates and further activates Akt, which localizes to the cellular membrane (1). Activated Akt fulfills various biological functions, including activating cAMP-response element binding protein (2), inhibiting p27 (3), localizing forkhead box protein O (FOXO) in the cytoplasm (3), activating phosphatidylinositol 3-phosphate (PtdIns3 ps or PI3P) (4) and activating mammalian target of rapamycin (mTOR) (3). It has been identified that the PI3K/Akt pathway can be enhanced by several biological molecules, including epidermal growth factor (EGF) (5), sonic hedgehog (2), insulin-like growth factor (IGF)-1 (2), insulin (3) and calmodulin (4). Conversely, this pathway
Molecular Medicine Reports PI3K/Akt signaling transduction pathway, erythropoiesis and glycolysis in hypoxia (Review) About About Spandidos Aims and Scopes Abstracting and Indexing Editorial Policies Reprints and Permissions Job Opportunities Terms and Conditions Contact Journals All Journals Oncology Letters Oncology Letters Information for Authors Editorial Policies Editorial Board Aims and Scope Abstracting and Indexing Bibliographic Information Archive International Journal of Oncology International Journal of Oncology Information for Authors Editorial Policies Editorial Board Aims and Sco
saved by
related reading
- The development and benefits of metformin in various diseaseslink.springer.com
- Metformin and Its Benefits for Various Diseasesncbi.nlm.nih.gov
- Differential roles of ERRFI1 in EGFR and AKT pathway regulation affect cancer proliferationpmc.ncbi.nlm.nih.gov
- p53 - Wikipediaen.wikipedia.org
- Imidazole ketone erastin induces ferroptosis and slows tumor growth in a mouse lymphoma modelpmc.ncbi.nlm.nih.gov
- The novel mechanism of lenalidomide activity - PMCncbi.nlm.nih.gov
- The current state of the art and future trends in RAS-targeted cancer therapiesnature.com
- Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemianature.com
- Gene 33/Mig6/ERRFI1, an Adapter Protein with Complex Functions in Cell Biology and Human Diseases - PMCpmc.ncbi.nlm.nih.gov
- Loss and revival of androgen receptor signaling in advanced prostate cancernature.com
- Similar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistance - PMCncbi.nlm.nih.gov
- RUNX1 mutations promote leukemogenesis of myeloid malignancies in ASXL1-mutated leukemia - PubMedpubmed.ncbi.nlm.nih.gov